<DOC>
	<DOCNO>NCT01536691</DOCNO>
	<brief_summary>The purpose study assess efficacy safety Ramosetron , Aprepitant Dexamethasone therapy versus Ondansetron , Aprepitant Dexamethasone therapy prevent nausea vomit highly emetogenic chemotherapy ( ROAD study ) : Prospective multicenter , randomize , single blind , phase III study .</brief_summary>
	<brief_title>Ramosetron , Aprepitant Dexamethasone Versus Ondansetron , Aprepitant Dexamethasone</brief_title>
	<detailed_description>To assess efficacy safety Ramosetron , Aprepitant Dexamethasone therapy versus Ondansetron , Aprepitant Dexamethasone therapy prevent nausea vomit highly emetogenic chemotherapy ( ROAD study ) :</detailed_description>
	<mesh_term>Dexamethasone acetate</mesh_term>
	<mesh_term>Dexamethasone</mesh_term>
	<mesh_term>Aprepitant</mesh_term>
	<mesh_term>Fosaprepitant</mesh_term>
	<mesh_term>Ramosetron</mesh_term>
	<mesh_term>Ondansetron</mesh_term>
	<mesh_term>Dexamethasone 21-phosphate</mesh_term>
	<mesh_term>BB 1101</mesh_term>
	<criteria>1 . Patients diagnosed malignancy treat highly emetogenic chemotherapeutic agent ( NCCN guideline v1.0 2011 antiemesis ) , 20 year sex 2 . ECOG performance status 02 3 . Available oral administration study drug 4 . Patients must sign informed consent indicate aware investigational nature study keep policy hospital 1 . Severe Hypertension , severe Heart disease , kidney disease ( serum creatinine &gt; 3 mg/dl ) , liver disease ( AST , ALT &gt; 3 time upper normal range , ALP &gt; 2 time upper normal range ) 2 . Patients GI obstruction , active gastric ulcer disease could provoke nausea vomit 3 . Patients nausea vomit within 1 week chemotherapy 4 . Patients take steroid , antiemetic , pimozide , terfenadine , astemizole , cisapride , rifampin , carbamazepine , phenytoin , ketoconazole , itraconazole , nefazodone , troleandomycin , clarithromycin , ritonavir nelfinavir treatment diseases 5 . Patients brain tumor , brain metastasis seizure 6 . Patients receive chemotherapy within 12 month enrollment 7 . Patients need radiation therapy study period receive radiation therapy within 2 week chemotherapy 8 . Patients know allergy severe side effect study drug 9 . Pregnant lactate woman , woman wish become pregnant 10 . Others investigator judge inappropriate subject study</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2012</verification_date>
	<keyword>ramosetron</keyword>
	<keyword>ondansetron</keyword>
	<keyword>aprepitant</keyword>
	<keyword>chemotherapy induce nausea &amp; vomiting</keyword>
</DOC>